Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • HOME
  • ABOUT US
  • POLICY HUB
  • OUR VALUES
  • OUR SERVICES
  • PRIVACY POLICY
  • CONTACT US

Insight, China's Pharmaceutical Industry Fineline Info & Tech is a comprehensive global pharmaceutical database that spans the entire product lifecycle. Its mission is to equip professionals and executives across all sectors of the life sciences industry with a standardized data language, offering a holistic view of the Chinese pharmaceutical competitive landscape. Flcube.com furnishes critical data essential for informed decision-making, drawing on global industry news, policy insights, competitive intelligence, and advanced analytical tools.

Company Deals PIC

Suzhou AsiFlyer Biotechnology Secures Exclusive Worldwide License from ShanghaiTech University for AI‑Designed Recombinant Botulinum Toxin Patent

Fineline Cube Sep 8, 2026
Company Deals PIC

Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co‑Develop LCUGZ1007 – Next‑Generation E‑PDC Probody Drug Conjugate

Fineline Cube Sep 8, 2026
Company Deals PIC

China Biotech’s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK – Launching Cross‑Border BNCT Oncology Cooperation

Fineline Cube Sep 8, 2026
Company Deals PIC

Guangdong Taienkang Completes Capital Increase in Procapzoom – Secures Exclusive China Rights to World‑First Ocular Surface Cell Therapy SZ018

Fineline Cube Sep 8, 2026
Company Deals PIC

HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next‑Generation Drug R&D Systems

Fineline Cube Sep 7, 2026
Company Deals PIC

Suzhou AsiFlyer Biotechnology Secures Exclusive Worldwide License from ShanghaiTech University for AI‑Designed Recombinant Botulinum Toxin Patent

Fineline Cube Sep 8, 2026
Company

BD Opens Tianjin Life Health Innovation Center With Seven Clinical Training Centers – Establishing a Northern China Hub Built on an “Experience – Training – R&D” Trinity for High‑End Medical Devices

Fineline Cube Sep 9, 2026
Company Drug

CSPC Pharmaceutical Wins NMPA Clinical Trial Approval for SYH2083 Eye Drops – A Class 1 Innovative Small‑Molecule Ophthalmic Drug Targeting Ocular Surface Inflammation via T‑Cell Adhesion and Activation

Fineline Cube Sep 9, 2026
Company Drug

HutchMed Launches Phase II/III Study for Sovleplenib in Autoimmune Hemolytic Anemia

Fineline Cube Mar 22, 2024

HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced the initiation of the Phase II/III...

Company Drug

NeuExcell Therapeutics Doses First Patient in Groundbreaking Clinical Trial for NeuroD1 Gene Therapy

Fineline Cube Mar 22, 2024

NeuExcell Therapeutics, a Shanghai-based developer of in vivo neural regenerative therapies, has announced the first...

Company Deals

Astra Biotech Raises Tens of Millions in Pre-Series B Funding to Expand Diagnostic Capabilities

Fineline Cube Mar 22, 2024

Astra Biotech, a developer of single molecule immunodiagnostic technology based in Suzhou, has reportedly raised...

Company Deals

Horimed Secures Tens of Millions in Financing to Advance OCT Imaging Technologies

Fineline Cube Mar 22, 2024

Horimed, a Tianjin-based manufacturer of OCT imaging equipment, has reportedly raised “tens of millions” of...

Company Deals

Beijing Varnotech Biopharm Secures RMB 600 Million in Series B Funding for Vaccine Development

Fineline Cube Mar 22, 2024

Beijing Varnotech Biopharm Ltd, a China-based specialist in human vaccines, has successfully raised RMB 600...

Company Deals

PoreSpect Secures Tens of Millions in Angel Funding Led by Forcefield Ventures

Fineline Cube Mar 22, 2024

PoreSpect, a Guangdong-based manufacturer of devices and consumables, has reportedly secured “tens of millions” of...

Company Medical Device

Intuitive Surgical’s Ion Robotic System Gains Regulatory Approval in China

Fineline Cube Mar 22, 2024

Intuitive Surgical (NASDAQ: ISRG), a leading medical robotics firm based in the US, has announced...

Company

Henlius Biotech Posts 67.8% YOY Revenue Growth and First Annual Profit in 2023 Financials

Fineline Cube Mar 22, 2024

Shanghai Henlius Biotech Inc., (HKG: 2696) has released its financial results for 2023, reporting revenues...

Company

Bayer Eliminates C-Level Roles in Restructuring Efforts to Boost Profitability

Fineline Cube Mar 22, 2024

Germany’s Bayer (ETR: BAYN) has taken significant steps in its restructuring efforts by eliminating 8...

Company Deals Digital

Baidu Health Partners with Yibang to Enhance Operations for Brick-and-Mortar Pharmacies

Fineline Cube Mar 21, 2024

Baidu Health has entered into a strategic partnership with Shanghai Yibang Medicine Information Technology Co.,...

Company Deals

Edan Instruments Partners with Global Health Labs to Develop AI-Enhanced Handheld Ultrasound

Fineline Cube Mar 21, 2024

Shenzhen-based Edan Instruments Inc. has forged a strategic partnership with Global Health Labs Inc. to...

Company Drug

FDA Grants Accelerated Approval for Takeda’s Iclusig in Newly Diagnosed Ph+ ALL

Fineline Cube Mar 21, 2024

The U.S. Food and Drug Administration (FDA) has granted accelerated indication extension approval to Japan’s...

Policy / Regulatory

China Unveils Action Plan to Boost Foreign Investment and Open Economy Further

Fineline Cube Mar 21, 2024

The State Council of China has unveiled an ambitious “Action Plan to Promote the High-Level...

Company

Simcere Pharmaceutical Reports 4.5% Revenue Growth in 2023 Amid Shifts in Profitability

Fineline Cube Mar 21, 2024

Simcere Pharmaceutical Group (HKG: 2096), based in China, has released its 2023 financial performance report,...

Company Deals

Sinopharm and Fresenius Kabi Expand Partnership to Enhance Drug Distribution and Healthcare Services

Fineline Cube Mar 21, 2024

China’s state-owned Sinopharm Group Co., Ltd. (HKG: 1099) has announced a new partnership with Germany’s...

Company Deals

Bayer and Thermo Fisher Partner to Develop Rapid Companion Diagnostics for Precision Oncology

Fineline Cube Mar 21, 2024

Germany’s Bayer (NYSE: BAYE) has entered into a strategic partnership with U.S. life sciences leader...

Company Drug

iRegene’s NouvSight001 Gains Orphan Drug Designation for Retinitis Pigmentosa Treatment

Fineline Cube Mar 21, 2024

Wuhan-based cell therapy innovator iRegene has secured Orphan Drug Designation (ODD) from the U.S. FDA...

Company Drug

BMS Reports Positive Phase III Results for Opdivo and Yervoy in Advanced HCC

Fineline Cube Mar 21, 2024

Bristol Myers Squibb (BMS; NYSE: BMY) announced this week that its Phase III study evaluating...

Company Deals

China Resources Guangdong Pharmaceutical Partners with BD to Enhance Drug and Device Distribution in GBA

Fineline Cube Mar 21, 2024

China Resources Guangdong Pharmaceutical Co., Ltd has entered into a strategic partnership with U.S.-based Becton,...

Digital R&D

CAIR Launches CARES Copilot 1.0: A Revolutionary AI Chatbot for Medical Diagnosis and Treatment

Fineline Cube Mar 21, 2024

The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences...

Posts pagination

1 … 438 439 440 … 718

Recent updates

  • BD Opens Tianjin Life Health Innovation Center With Seven Clinical Training Centers – Establishing a Northern China Hub Built on an “Experience – Training – R&D” Trinity for High‑End Medical Devices
  • CSPC Pharmaceutical Wins NMPA Clinical Trial Approval for SYH2083 Eye Drops – A Class 1 Innovative Small‑Molecule Ophthalmic Drug Targeting Ocular Surface Inflammation via T‑Cell Adhesion and Activation
  • Gilead Sciences Opens 182,000‑Square‑Foot Research Center at Foster City Headquarters – Expanding Oncology, Inflammation, and Research Data Science Capabilities as Part of a Three‑Project US Investment Program Through 2030
  • Windward Bio Reports Positive POLARIS‑1 Phase 2 Interim Results for HBM9378/WIN378 – An Ultra‑Long‑Acting TSLP Antibody in Asthma – as the Phase 3 Portion Begins
  • China’s NHC Issues Eye Health Services Work Plan for 2026–2030 – Setting 2030 Targets on Cataract Surgery Rates, Ophthalmologist Workforce Density, and County‑Level Vision Care Capacity
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • PIC
  • Policy / Regulatory
  • R&D

You Missed

Company

BD Opens Tianjin Life Health Innovation Center With Seven Clinical Training Centers – Establishing a Northern China Hub Built on an “Experience – Training – R&D” Trinity for High‑End Medical Devices

Company Drug

CSPC Pharmaceutical Wins NMPA Clinical Trial Approval for SYH2083 Eye Drops – A Class 1 Innovative Small‑Molecule Ophthalmic Drug Targeting Ocular Surface Inflammation via T‑Cell Adhesion and Activation

Company

Gilead Sciences Opens 182,000‑Square‑Foot Research Center at Foster City Headquarters – Expanding Oncology, Inflammation, and Research Data Science Capabilities as Part of a Three‑Project US Investment Program Through 2030

Company Drug

Windward Bio Reports Positive POLARIS‑1 Phase 2 Interim Results for HBM9378/WIN378 – An Ultra‑Long‑Acting TSLP Antibody in Asthma – as the Phase 3 Portion Begins

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

© 2026 Fineline Information & Technology. Independent intelligence on China's pharmaceutical industry. Not investment advice. | BlogData by Themeansar.